Organization
Personal Genome Diagnostics (Labcorp)
4 abstracts
Abstract
The impact of single gene testing (SGT) on subsequent comprehensive genomic profiling (CGP) success in community oncology practice for advanced non-small cell lung cancer (NSCLC): Results from a prospective observational reference laboratory testing program.Org: Durham, NC, Labcorp Oncology, Nykode Therapeutics, Buffalo, Duke University Medical Center,
Abstract
Comparison of immune microenvironment between primary and metastatic breast tumors.Org: Labcorp Oncology, Duke University Medical Center, Duke Cancer Institute, Department of Pathology, Durham, NC, OmniSeq (Labcorp), Roswell Park Comprehensive Cancer Center, OmniSeq, Inc., Personal Genome Diagnostics (Labcorp),
Abstract
Liquid biopsy-informed precision oncology study to evaluate utility of plasma genomic profiling for therapy selection.Org: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins School of Medicine, Sidey Kimmel Comprehensive Cancer Center, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine, Johns Hopkins University School of Medicine,
Abstract
Effect of homologous recombination deficient (HRD) breast cancers on a distinct immune marker phenotype by comprehensive genomic and immune profiling (CGIP).Org: Labcorp Oncology, Duke University Medical Center, Duke Cancer Institute, Department of Pathology, Durham, NC, OmniSeq (Labcorp), Duke University Medical Center, Duke Cancer Institute, OmniSeq, Inc.,